Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors.

Abstract:

:Dendritic cells (DCs) as 'professional' antigen-presenting cells (APCs) initiate and regulate immune responses to various antigens. DC-based vaccines have become a promising modality in cancer immunotherapy. Cytokeratin 19 (CK19) protein is expressed at high levels in lung cancer and many other tumor cells, suggesting CK19 as a potential tumor‑specific target for cancer immune therapy. We constructed a recombinant adenoviral vector containing the CK19 gene (rAd-CK19). DCs transfected with rAd-CK19 were used to vaccinate C57BL/6 mice bearing xenografts derived from Lewis lung carcinoma (LLC) cells. The transfected DCs gave rise to potent CK19-specific cytotoxic T lymphocytes (CTLs) capable of lysing LLC cells. Mice immunized with the rAd‑CK19-DCs exhibited significantly attenuated tumor growth (including tumor volume and weight) when compared to the tumor growth of mice immunized with rAd-c DCs or DCs during the 24-day observation period (P<0.05). The results revealed that the mice vaccinated with the rAd-CK19-DCs exhibited a potent protective and therapeutic antitumor immunity to LLC cells in the subcutaneous model along with an inhibitive effect on tumor growth compared to the mice vaccinated with the rAd-c DCs or DCs alone. The present study proposes a meaningful mode of action utilizing rAd-CK19 DCs in lung cancer immunotherapy.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Sun QF,Zhao XN,Peng CL,Hao YT,Zhao YP,Jiang N,Xue H,Guo JZ,Yun CH,Cong B,Zhao XG

doi

10.3892/or.2015.4231

subject

Has Abstract

pub_date

2015-11-01 00:00:00

pages

2289-95

issue

5

eissn

1021-335X

issn

1791-2431

journal_volume

34

pub_type

杂志文章
  • The stem cell marker nestin predicts poor prognosis in human melanoma.

    abstract::The cancer stem cell hypothesis suggests that mutated melanocyte stem cells are present in skin as precursors of melanoma cells. Nestin and CD133 have been described as markers of melanocytic stem cells. The aim of this study was to establish if melanocytic stem cells could have a prognostic significance in melanoma p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Piras F,Perra MT,Murtas D,Minerba L,Floris C,Maxia C,Demurtas P,Ugalde J,Ribatti D,Sirigu P

    更新日期:2010-01-01 00:00:00

  • Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review).

    abstract::The long-term effort in investigating chemical methods to eliminate only cancer cells has improved our knowledge and has led to the development of new drugs. The targets for cancer treatment may be large polymeric molecules such as DNA or microtubules as well as regulatory pathways for tumor development and cell survi...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.9.6.1257

    authors: Stathopoulos GP

    更新日期:2002-11-01 00:00:00

  • HLA-B gene participates in the NF-kappaB signal pathway partly by regulating S100A8 in the laryngeal carcinoma cell line Hep2.

    abstract::Human leukocyte antigen B (HLA-B), a novel member of the NF-kappaB signal pathway in laryngeal squamous cell carcinoma (LSCC), mediates immunological surveillance of tumor cells by presenting peptides to cytotoxic T-lymphocytes (CTLs) together with S100 calcium binding protein A8 (S100A8). The objective of this study ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Guo Y,Liu J,Xu Z,Sun K,Fu W

    更新日期:2008-06-01 00:00:00

  • MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.

    abstract::As a common malignancy of the endocrine system, papillary thyroid carcinoma (PTC) seriously affects the quality of life of patients. lncRNA PAX8‑AS1:28, or lnc‑PSD4‑1:14 has been reported to be abnormally expressed in PTC. However, the function of PAX8‑AS1:28 in PTC is still unknown. Therefore, the present study aimed...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.6996

    authors: Zhang Y,Li F,Chen J

    更新日期:2019-04-01 00:00:00

  • Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.

    abstract::In breast cancer, neuregulin-1 (NRG1) is known as a ligand for the HER3 receptor, which has no intrinsic tyrosine kinase activity. When activated by NRG1 binding, the HER3 receptor forms a heterodimer with other HER family receptors and mediates downstream signaling pathways, leading to multiple effects including grow...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3330

    authors: Jeong H,Kim J,Lee Y,Seo JH,Hong SR,Kim A

    更新日期:2014-09-01 00:00:00

  • Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).

    abstract::The medicinal properties of extracts from the hemp plant Cannabis sativa have been known for centuries but only in the 90s membrane receptors for the Cannabis major principle were discovered in mammalian cells. Later on the endogenous ligands for the cannabinoid receptors were identified and the term 'endocannabinoid ...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:

    authors: Bifulco M,Laezza C,Gazzerro P,Pentimalli F

    更新日期:2007-04-01 00:00:00

  • Mutational analysis of Smad7 in human cervical cancer.

    abstract::Our aim was to carry out mutational analysis of Smad7 exon 4 that codes for the Smad7 MH2 domain in human cervical cancer tissues. This study is warranted since genetic abnormalities of components of the transforming growth factor-beta (TGF-beta)/Smad signaling system have been implicated in a variety of human cancers...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000315

    authors: Hariharan R,Babu JM,P R,Pillai MR

    更新日期:2009-04-01 00:00:00

  • Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer.

    abstract::Tumor invasion, angiogenesis and metastasis involve secretion of proteolytic enzymes and cell migration into blood vessels. Tumor cells are capable of degrading the extracellular matrix via a proteolytic cascade that includes urokinase-type plasminogen activator (uPA) and matrix metalloproteases (MMPs). We have invest...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Farina HG,Pomies M,Alonso DF,Gomez DE

    更新日期:2006-10-01 00:00:00

  • MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7.

    abstract::MicroRNAs (miRNAs) are small non-coding RNAs of 20-25 nucleotides in length that are capable of modulating gene expression post-transcriptionally. The potential roles of miRNAs in the tumorigenesis of glioblastoma (GBM) have been under intensive studies in the past few years. In the present study, we found a positive ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3055

    authors: Jiang H,Hua D,Zhang J,Lan Q,Huang Q,Yoon JG,Han X,Li L,Foltz G,Zheng S,Lin B

    更新日期:2014-05-01 00:00:00

  • Long non‑coding RNA00887 reduces the invasion and metastasis of non‑small cell lung cancer by causing the degradation of miRNAs.

    abstract::Long non‑coding RNAs (lncRNAs) can act as carcinogenic or cancer suppressive factors during the pathogenesis, invasion and metastasis of non‑small cell lung cancer (NSCLC). The current study explored the role of long intergenic non‑protein coding RNA 00887 (LINC00887) and competing endogenous RNAs (ceRNAs). It was rev...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7228

    authors: Tian Y,Yu M,Sun L,Liu L,Huo S,Shang W,Sheng S,Wang J,Sun J,Hu Q,Dou Y,Zhu J,Ren X,Yang S

    更新日期:2019-09-01 00:00:00

  • Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.

    abstract::Activating mutations of Ras gene families have been found in a variety of human malignancies, including lung cancer, suggesting their dominant role in tumorigenesis. Many studies have showed that the Kras gene is activated by point mutations in approximately 15-20% of non-small cell lung cancers (NSCLCs), however, the...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Sasaki H,Okuda K,Kawano O,Endo K,Yukiue H,Yokoyama T,Yano M,Fujii Y

    更新日期:2007-09-01 00:00:00

  • Histological features of extratumoral breast lesions as a predictive factor of familial breast cancer.

    abstract::The aim of this study was to verify whether histopathological features of extratumoral and of primary tumor breast tissue could play a role in identifying patients with familial characteristics. We examined the clinicopathological features of 504 patients with sporadic or familial breast cancer stratified for risk of ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000806

    authors: Mangia A,Tommasi S,Bruno M,Malfettone A,D'Amico C,Zito FA,Paradiso A,Simone G

    更新日期:2010-06-01 00:00:00

  • Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene delivery.

    abstract::The advent of pathotropic (disease-seeking) targeting has transported genetic medicine across the threshold of history with the progressive clinical validation of Rexin-G, a tumor-targeted nanosized anti-cancer agent. Achieving noteworthy single-agent efficacy and survival benefits in otherwise intractable cancers, th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.829

    authors: Hall FL,Levy JP,Reed RA,Petchpud WN,Chua VS,Chawla SP,Gordon EM

    更新日期:2010-10-01 00:00:00

  • The histone deacetylase inhibitor, Trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cells.

    abstract::Histone acetylation is one of the key chromatin modifications that control gene transcription during development and tumorigenesis. Recently, it was reported that the histone deacetylase inhibitor, Trichostatin A (TSA), induces growth arrest and apoptosis in tumors. However, the mol...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1496

    authors: Anh TD,Ahn MY,Kim SA,Yoon JH,Ahn SG

    更新日期:2012-02-01 00:00:00

  • Gene expression profiling of HL-60 cells following knockdown of nucleostemin using DNA microarrays.

    abstract::Nucleostemin (NS) plays an important role in tumorigenesis and progression. Most studies consider that NS plays its role through combining with p53 and inhibiting it, however our previous studies revealed that NS could also function without the existence of p53. To date, few studies have focused on the p53-independent...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3240

    authors: Sun X,Jia Y,Wei Y,Liu S,Yue B

    更新日期:2014-08-01 00:00:00

  • Exogenous hydrogen sulfide exerts proliferation, anti-apoptosis, migration effects and accelerates cell cycle progression in multiple myeloma cells via activating the Akt pathway.

    abstract::Hydrogen sulfide (H2S), regarded as the third gaseous transmitter, mediates and induces various biological effects. The present study investigated the effects of H2S on multiple myeloma cell progression via amplifying the activation of Akt pathway in multiple myeloma cells. The level of H2S produced in multiple myelom...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5014

    authors: Zheng D,Chen Z,Chen J,Zhuang X,Feng J,Li J

    更新日期:2016-10-01 00:00:00

  • Tanshinone IIA can inhibit MiaPaCa‑2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways.

    abstract::Tanshinone IIA (Tan‑IIA; C19H18O3) is derived from Danshen (the roots of Salvia miltiorrhiza), and has been reported to possess anti‑inflammatory and antioxidant activities. Tan‑IIA can inhibit BxPC‑3 human pancreatic cancer cells in vitro through inducing endoplasmic reticulum stress and apoptosis via mitochondrial p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6670

    authors: Su CC

    更新日期:2018-11-01 00:00:00

  • OCT4B1 promotes cell growth, migration and invasion suppressing sensitivity to οxaliplatin in colon cancer.

    abstract::OCT4B1, a splice variant of OCT4, is a key regulator in maintaining the properties of pluripotency and self-renewal in embryonic stem (ES) cells. Recent results have shown that OCT4B1 is involved in tumorigenesis. However, the contribution of OCT4B1 in the tumorigenesis and drug resistance of colon cancer remains to b...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4286

    authors: Wen KM,Zhang GH,Li J,Chen ZQ,Cheng YL,Su X,Zeng QL

    更新日期:2015-12-01 00:00:00

  • Splenic metastasis of lung cancer.

    abstract::Splenic metastasis from a lung cancer is infrequently noted, however, the pattern of the metastasis has not been studied, thus we conducted a retrospective study. Twelve of the consecutive 997 patients with lung cancer, who were admitted to our division, developed splenic metastasis. The pattern of splenic metastasis ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.6.1239

    authors: Satoh H,Watanabe K,Ishikawa H,Yamashita YT,Ohtsuka M,Sekizawa K

    更新日期:2001-11-01 00:00:00

  • DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.

    abstract::DEK, a transcription factor, is involved in mRNA splicing, transcriptional control, cell division and differentiation. Recent studies suggest that DEK overexpression can promote tumorigenesis in a wide range of cancer cell types. However, little is known concerning the status of DEK in pancreatic ductal adenocarcinoma...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5302

    authors: Sun J,Bi F,Yang Y,Zhang Y,Jin A,Li J,Lin Z

    更新日期:2017-02-01 00:00:00

  • Bioinformatics analysis of LINC01554 and its co‑expressed genes in hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is a leading cause of cancer‑related morbidity and mortality globally. Despite the remarkable improvements in comprehensive HCC treatment, the underlying mechanistic details of HCC remain elusive. We screened HCC patients for differentially expressed genes (DEGs) using the Gene Expressio...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7779

    authors: Li L,Huang K,Lu Z,Zhao H,Li H,Ye Q,Peng G

    更新日期:2020-11-01 00:00:00

  • E2F7, regulated by miR‑30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells.

    abstract::Prostate cancer (PCa) remains a leading cause of mortality among men in the United States and Western Europe. The molecular mechanism of PCa pathogenesis has not been fully elucidated. In the present study, the expression profile of E2F transcription factor 7 (E2F7) in PCa was examined using immunohistochemistry and r...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7659

    authors: Wang Y,Pei X,Xu P,Tan Z,Zhu Z,Zhang G,Jiang Z,Deng Z

    更新日期:2020-09-01 00:00:00

  • Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation.

    abstract::Reports indicate that, even in KRAS-mutated colon cancer, there are subsets of patients who benefit from anti-EGFR monoclonal antibody (MoAb) treatment. The aim of the present study was to identify genetic profiles that contribute to the responsiveness of metastatic colorectal cancer (mCRC) to anti-EGFR MoAb. We retro...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3179

    authors: Kishiki T,Ohnishi H,Masaki T,Ohtsuka K,Ohkura Y,Furuse J,Sugiyama M,Watanabe T

    更新日期:2014-07-01 00:00:00

  • MicroRNA-455 regulates migration and invasion of human hepatocellular carcinoma by targeting Runx2.

    abstract::MicroRNA-455 (miR-455) has been considered as a novel cancer-related miRNA and dysregulated expression frequently occurs in various human types of cancer. However, its clinical significance, its biological function and the underlying molecular signaling involved in hepatocellular carcinoma (HCC) remain to be elucidate...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5139

    authors: Qin L,Zhang Y,Lin J,Shentu Y,Xie X

    更新日期:2016-12-01 00:00:00

  • MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.

    abstract::MicroRNAs (miRs) have emerged as prospective tools for human cancer therapy, including hepatocellular carcinoma (HCC) therapy. Previous studies have suggested that miR-381 functions as oncogenic or tumor-suppressive miRs in other cancer types. However, the role of miR-381 in HCC remains unknown. The present study inve...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4491

    authors: Zhang Q,Zhao S,Pang X,Chi B

    更新日期:2016-03-01 00:00:00

  • Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors.

    abstract::The immunohistochemical expression of type 1 blood group antigens (type 1 BGAs) was analyzed for 30 cases of testicular germ cell tumors (TGCTs), using monoclonal antibodies against DU-PAN-2, CA19-9, Lewis(a) (Le(a)), and Lewis(b) (Le(b)). DU-PAN-2 was expressed very frequently in all of the embryonal carcinomas (ECs)...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.9.4.845

    authors: Kamoshida S,Satoh Y,Yasuda M,Kajiwara H,Tsukinoki K,Osamura RY

    更新日期:2002-07-01 00:00:00

  • MicroRNA‑192 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting caveolin 1.

    abstract::It has been demonstrated that microRNA‑192 (miR‑192) serves important roles in different cancer types, including breast cancer, prostate cancer and colorectal cancer. However, its biological role and function in breast cancer remains largely unknown. The present study aimed to determine the role of miR‑192 in breast c...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7298

    authors: Chen P,Feng Y,Zhang H,Shi X,Li B,Ju W,Yu X,Zhang N,Luo X

    更新日期:2019-11-01 00:00:00

  • miR-17-5p promotes the growth of osteosarcoma in a BRCC2-dependent mechanism.

    abstract::MicroRNA-17-5p has been proven upregulated in many human malignancies and correlated with tumor progression. However, its expression and clinical significance in osteosarcoma is still unclear. Thus, the aim of the present study was to explore the effects of miR-17-5p in osteosarcoma tumorigenesis and development. The ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4542

    authors: Wang W,Zhang L,Zheng K,Zhang X

    更新日期:2016-03-01 00:00:00

  • Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.

    abstract::Immature colon carcinoma transcript-1 (ICT1) is a newly identified oncogene, which regulates proliferation, cell cycle progression and apoptosis of cancer cells. However, the clinical significance, biological function and underlying mechanisms of ICT1 in hepatocellular carcinoma (HCC) remain poorly known. In the prese...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.6046

    authors: Chang W,Yu Z,Tian M,Lin X

    更新日期:2017-12-01 00:00:00

  • MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7.

    abstract::MicroRNAs (miRNAs) are a group of important regulators in human types of cancer including non-small cell lung cancer (NSCLC). miR-616 has been found to be a novel cancer-related miRNA. However, the expression and biological function of miR-616 in NSCLC have not been investigated. In this study, qRT-PCR was performed t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5854

    authors: Wang D,Cao Q,Qu M,Xiao Z,Zhang M,Di S

    更新日期:2017-10-01 00:00:00